Filters Applied:
Cardiologists are struggling to figure out why a drug that should have prevented heart attacks didn’t work at all.
| Keywords | healthcaremedicinenytimespharmaceuticalsclinical-trialshealthmedical-researchsciencebiotechfdabig-pharmacardiologycholesteroldoctorheart-diseasegina-kolatanovartis |
A small gene-editing study significantly reduced LDL cholesterol levels, and the results have stuck a year later.
| Keywords | healthmedicinehealthcaresciencecholesterolglp-1weight-lossdiabetesheart-healthmedicationobesityfdanytimesbiotechgene-editingclinical-studymedical-news |
Dr. Chauncey Crandall joined “Bianca Across the Nation” to discuss the benefits of Lipfendra, a daily pill recently approved by the FDA designed to dramatically lower bad cholesterol by nearly 60%.
| Keywords | cholesterollipfendrafdadr-chauncey-crandallmedicinehealthcarecardiologyheart-healthpublic-healthnewly-approvedmedical-newsdrug-breakthroughlifestylewellnessusanewsmaxbianca-across-the-nation |
The Food and Drug Administration (FDA) has approved a new pill that lowers cholesterol.
The Food and Drug Administration has approved a cholesterol-lowering daily pill called Lipfendra, expanding treatment possibilities beyond statins and injectables. PULSE POINTS WHAT HAPPENED: - DETAIL: On Thursday, the FDA approved Lipfendra , a new cholesterol-lowering pill. Developed by Merck, a German pharmaceutical multinational, Lipfendra belongs to the PCSK9 inhibitor class of medications. PCSK9 is a liver-produced enzyme that regulates blood cholesterol levels. The pill is the first of its kind, as previous PCSK9 inhibitors were only available as injections. The pill is designed to be taken daily. Lipfendra is intended to help patients with hypercholesterolemia, or high LDL, known widely as “bad” cholesterol. According to…Open
How does it compare to statins? Should you take it? And how much does it cost?
Clinical trials have shown that Lipfendra can bring levels of LDL, the bad type of cholesterol, down 60%.
| Keywords | cholesterolldllipfendrafdamedicinehealthcarepharmaceuticalsdrug-approvalhealthwellnessmedicalclinical-trialsheart-healthmedication |
The new pills can lower cholesterol levels far below what can be achieved with statins, clinical trials have shown.
| Keywords | healthcholesterolmedicinestatinsfdapharmaceuticalscardiac-careheart-healthmedical-breakthroughsciencebiotechhealthcarenytnytimesgina-kolatapublic-healthdoctorwellnesspreventionlifestyle |
Decades of scientific investment have paid off just in the last month, with researchers announcing promising breakthroughs against cancers and other deadly afflictions. Why it matters: They're all the product of a rigorous innovation system that delivers — though some have one important limitation: All they can do is buy someone a few more years. The big picture: We're still in the era of medicine where most miraculous new drugs don't cure the disease as much as allow sick people to live longer. - In economic terms, that ongoing medical care is expensive, and long-term diseases usually limit the number of years people are productive while increasing their lifetime medical costs. Driving the news: Recent weeks have featured a series of…
President Trump 's medical checkups have turned into mini dramas pitting the public's right to know against a public figure's medical privacy — with a heavy overlay of political intrigue. The big picture: The White House added another twist late Friday night by releasing a three-page memo summarizing Trump's visit to Walter Reed Military Medical Center the prior Tuesday that concluded he was "in excellent health" and "fully fit" to carry out all of his duties. - It took three days to release the findings, which arrived at 10:44pm ET on a Friday night. - And while they were more comprehensive than some past readouts, the memo from White House physician Sean Barbabella didn't put to rest persistent questions about about apparent…
A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial. The results may point to something “curative,” one expert said.